The PGY-2 Investigational Drugs and Research Pharmacy residency program at UTSW is a one-year post-graduate training program designed to provide an opportunity for the residents to develop strong clinical foundation, knowledge, leadership skills and experience to specialize in clinical research and investigational drug services.

Purpose

PGY-2 pharmacy residency program will provide residents with opportunities to function as independent practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete the program will be prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Rotations

Residents will gain experience and training in the following clinical service areas:

• Orientation (4 weeks)
• Investigational Drug Service Pharmacy Leadership & Management (5 weeks)
• Investigational Drug Service Oncology Pharmacy Operations I (4 weeks)
• Investigational Drug Service Oncology Pharmacy Operations II (4 weeks)
• Inpatient Investigational Drug Service (5 weeks)
• Outpatient Oncology (Solid-Tumor): Direct Patient Care (4 weeks)
• Medication Safety and Quality (5 weeks)
• Clinical Research Office Oncology (4 weeks)
• Phase 1 Clinical Trial – Oncology (4 weeks)

Elective Rotations

• Clinical Study Pharmacology (3–4 weeks)
• Informatics and Data Management (3–4 weeks)
• Outpatient Oncology (Heme-Malignancy): Direct Patient Care (4 weeks)

Longitudinal Experiences

• IDS Longitudinal Research Project (52 weeks with 4-6 weeks of dedicated research time)
• IDS Longitudinal Staffing (52 weeks scheduled every third week or weekend)
• Institutional Review Board Longitudinal Rotation (3-4 months)
• Protocol Review and Monitoring Committee Longitudinal Rotation (6 months)

Optional Longitudinal Rotation

• Teaching Certificate (available if not completed as PGY1)

Program Expectations

• ACPE-accredited CE presentation
• Major research project and manuscript
• Present major research project at a regional or national meeting

Current Resident

Christina Baroody

Christina.Baroody@UTSouthwestern.edu

Christina Baroody is a PGY-2 Investigational Drugs and Research Resident at UT Southwestern Medical Center. Dr. Baroody earned her Doctor of Pharmacy from the Lebanese American University, and she completed her PGY-1 Pharmacy Residency at the Lebanese American University Medical Center – Rizk Hospital in Beirut, Lebanon.

She decided to pursue the Investigational Drugs and Research specialty at UTSW because she is highly interested in clinical research and the development of new drugs. Her pharmacy interests include immunotherapy, cardiology, and clinical trial management.

She is a member of the American Society of Health-System Pharmacists and American College of Clinical Pharmacy. Outside of pharmacy, she enjoys reading, practicing yoga, and exploring new restaurants. Though most of the time, you would probably catch her making phone-calls with friends and family that are overseas.